Fitt Insider cover image

328. Kat Cole, CEO of AG1

Fitt Insider

00:00

Why AG1 invests heavily in clinical trials

Kat explains the dual reasons for research: to guide formulation and to build trust amid category confusion.

Play episode from 20:42
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app